Cardiac Amyloidosis (TTR) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Cardiac Amyloidosis (TTR)
Cardiac amyloidosis TTR is a serious condition where abnormal proteins build up in the heart, leading to heart failure. Managing this disease often involves expensive specialized medications. TheDrugClub offers a simple solution, providing significant savings on prescription costs, making vital treatments more accessible for individuals and families facing this challenging diagnosis.
What is Cardiac Amyloidosis TTR?
Cardiac amyloidosis TTR, or Transthyretin Amyloid Cardiomyopathy (ATTR-CM), is a progressive and often underdiagnosed heart condition. It occurs when a protein called transthyretin (TTR) misfolds and accumulates as amyloid fibrils in the heart muscle. These deposits stiffen the heart, making it harder to pump blood effectively, eventually leading to heart failure and other complications. TTR amyloidosis can be hereditary (passed down through families) or wild-type (age-related, with no genetic link). Early diagnosis is crucial for
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.